Patents by Inventor Wendy Winckler Adamovich

Wendy Winckler Adamovich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment
    Patent number: 11851697
    Abstract: The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
    Type: Grant
    Filed: January 11, 2022
    Date of Patent: December 26, 2023
    Assignee: Glympse Bio, Inc.
    Inventors: Faycal Touti, Wendy Winckler Adamovich, Sophie Cazanave, Mehar Cheema, Robert S. Langer
  • EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT
    Publication number: 20230175037
    Abstract: The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
    Type: Application
    Filed: December 9, 2022
    Publication date: June 8, 2023
    Inventors: Faycal Touti, Wendy Winckler Adamovich, Sophie Cazanave, Mehar Cheema, Robert S. Langer
  • Ex vivo protease activity detection for disease detection/diagnostic, staging, monitoring and treatment
    Patent number: 11604193
    Abstract: The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
    Type: Grant
    Filed: January 11, 2022
    Date of Patent: March 14, 2023
    Assignee: GLYMPSE BIO, INC.
    Inventors: Faycal Touti, Wendy Winckler Adamovich, Sophie Cazanave, Mehar Cheema, Robert S. Langer
  • EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT
    Publication number: 20220178935
    Abstract: The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
    Type: Application
    Filed: January 11, 2022
    Publication date: June 9, 2022
    Inventors: Faycal Touti, Wendy Winckler Adamovich, Sophie Cazanave, Mehar Cheema, Robert S. Langer
  • EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT
    Publication number: 20220128546
    Abstract: The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
    Type: Application
    Filed: January 11, 2022
    Publication date: April 28, 2022
    Inventors: Faycal Touti, Wendy Winckler Adamovich, Sophie Cazanave, Mehar Cheema, Robert S. Langer
  • EX VIVO PROTEASE ACTIVITY DETECTION FOR DISEASE DETECTION/DIAGNOSTIC, STAGING, MONITORING AND TREATMENT
    Publication number: 20220128567
    Abstract: The present application provides compositions and methods for determining a disease or condition in a subject. The method comprises contacting a body fluid with a molecule comprising a reporter thereof and the reported is cleaved by an agent in the body fluid. Diseases and conditions that can be determined by the method are also described.
    Type: Application
    Filed: January 11, 2022
    Publication date: April 28, 2022
    Inventors: Faycal Touti, Wendy Winckler Adamovich, Sophie Cazanave, Mehar Cheema, Robert S. Langer